Degradation kinetics of Benzonatate (cas 104-31-4) in aqueous solutions
-
Add time:08/14/2019 Source:sciencedirect.com
The decomposition of Benzonatate (cas 104-31-4) in aqueous solutions followed apparent first-order kinetics. One major hydrolysis product, 4-(butylamino)benzoic acid, was efficiently and completely separated from benzonatate with a validated HPLC. The apparent activation energies obtained from an Arrhenius plot was 16.07, 20.54 and 18.23 kcal mol−1 in buffer solutions with pH 3.61, 9.42 and 10.46, respectively, which indicated that hydrolysis dominated the degradation process. The buffer concentration showed significant effect on the hydrolysis of benzonatate (P<0.05). Specific acid-, specific base- and buffer catalyzed hydrolysis of benzonatate were observed in solutions with pH in the range of 0.31–12.21. The decomposition of benzonatate in basic solutions was faster than in acidic solutions by about 2000-fold. The prominent base-catalyzed breakdown of the ester bond and slower acid-catalyzed hydrolysis suggested that benzonatate should be prepared in the solutions with pH 3–7 to maximize its stability.
We also recommend Trading Suppliers and Manufacturers of Benzonatate (cas 104-31-4). Pls Click Website Link as below: cas 104-31-4 suppliers
Prev:Benzonatate (cas 104-31-4) inhibition of voltage-gated sodium currents
Next:Inhibition of cough-reflex sensitivity by Benzonatate (cas 104-31-4) and guaifenesin in acute viral cough) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Selected topic: ToxicologyCardiac Arrest With Residual Blindness After Overdose of Tessalon® (Benzonatate (cas 104-31-4)) Perles08/16/2019
- Inhibition of cough-reflex sensitivity by Benzonatate (cas 104-31-4) and guaifenesin in acute viral cough08/15/2019
- Benzonatate (cas 104-31-4) inhibition of voltage-gated sodium currents08/13/2019
- Genotoxicity assessment of the novel antitussive agent Benzonatate (cas 104-31-4) and its major metabolite08/12/2019
- Determination of Benzonatate (cas 104-31-4) and its metabolite in human plasma by HPLC–MS/MS: A preliminary pharmacokinetic study in healthy Chinese volunteers after oral administration of Benzonatate (cas 104-31-4) soft capsule08/11/2019